Literature DB >> 20399905

Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites.

Silvia Montoliu1, Belén Ballesté, Ramon Planas, Marco Antonio Alvarez, Mònica Rivera, Mireia Miquel, Helena Masnou, Isabel Cirera, Rosa Maria Morillas, Susanna Coll, Margarita Sala, Montserrat García-Retortillo, Nuria Cañete, Ricard Solà.   

Abstract

BACKGROUND & AIMS: Hepatorenal syndrome is a well-characterized type of terminal renal failure that occurs in patients with cirrhosis with ascites. Information about other types of functional renal failure in these patients is scarce. We assessed the incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites and investigated prognostic factors for these disorders.
METHODS: Consecutive cirrhotic patients (n = 263) were followed for 41 +/- 3 months after their first incidence of ascites. Three types of functional renal failure were considered: pre-renal failure (when renal failure was associated with a depletion of intravascular volume), renal failure induced by infection that did not result in hepatorenal syndrome, and hepatorenal syndrome.
RESULTS: During the follow-up period, 129 (49%) patients developed some type of functional renal failure. The most frequent was pre-renal failure (27.4%), followed by renal failure induced by infection (14.1%), and then hepatorenal syndrome (7.6%). The 1-year probability of developing the first episode of any functional renal failure was 23.6%. The independent predictors of functional renal failure development were baseline age, Child-Pugh score, and serum creatinine. Although the 1-year probability of survival was 91% in patients without renal failure, it decreased to 46.9% in those patients who developed any functional renal failure (P = .0001).
CONCLUSIONS: Approximately 50% of the cirrhotic patients with ascites developed some type of functional renal failure during the follow-up period; renal failure was associated with worse prognosis. Efforts should be made to prevent renal failure in cirrhotic patients with ascites. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20399905     DOI: 10.1016/j.cgh.2010.03.029

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  22 in total

Review 1.  [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].

Authors:  K Lenz; R Buder; G Lohr; P Piringer; M Voglmayr
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-30       Impact factor: 0.840

Review 2.  Acute renal injury after partial hepatectomy.

Authors:  Luis Alberto Batista Peres; Luis Cesar Bredt; Raphael Flavio Fachini Cipriani
Journal:  World J Hepatol       Date:  2016-07-28

Review 3.  Recent advances in our understanding of hepatorenal syndrome.

Authors:  Florence Wong
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

4.  Biomarkers of Renal Injury in Cirrhosis: Association with Acute Kidney Injury and Recovery after Liver Transplantation.

Authors:  Ashwani K Singal; Bradford Jackson; Glauber B Pereira; Kirk B Russ; Paul Stephen Fitzmorris; Donny Kakati; Page Axley; Sujan Ravi; Toni Seay; Satish P Ramachandra Rao; Ravindra Mehta; Yong-Fang Kuo; Karan P Singh; Anupam Agarwal
Journal:  Nephron       Date:  2017-09-02       Impact factor: 2.847

5.  Development of a rat model of D-galactosamine/lipopolysaccharide induced hepatorenal syndrome.

Authors:  Jing-Bo Wang; Hai-Tao Wang; Lu-Ping Li; Ying-Chun Yan; Wei Wang; Jing-Yang Liu; Yi-Tong Zhao; Wei-Shu Gao; Ming-Xiang Zhang
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

Review 6.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Authors:  Andrew M Moon; Amit G Singal; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-08       Impact factor: 11.382

7.  Outcome of hepatectomy for hepatocellular carcinoma in patients with renal dysfunction.

Authors:  Takeo Toshima; Ken Shirabe; Shohei Yoshiya; Jun Muto; Toru Ikegami; Tomoharu Yoshizumi; Yoshihiko Maehara
Journal:  HPB (Oxford)       Date:  2012-05       Impact factor: 3.647

8.  Treatment to improve acute kidney injury in cirrhosis.

Authors:  Florence Wong
Journal:  Curr Treat Options Gastroenterol       Date:  2015-06

9.  Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus.

Authors:  Juan P Arab; Juan C Claro; Juan P Arancibia; Jorge Contreras; Fernando Gómez; Cristian Muñoz; Leyla Nazal; Eric Roessler; Rodrigo Wolff; Marco Arrese; Carlos Benítez
Journal:  World J Hepatol       Date:  2016-09-08

Review 10.  Renal failure in cirrhosis: Emerging concepts.

Authors:  Paulo Lisboa Bittencourt; Alberto Queiroz Farias; Carlos Terra
Journal:  World J Hepatol       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.